Document Detail

Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?
MedLine Citation:
PMID:  22477829     Owner:  NLM     Status:  In-Data-Review    
Respiratory syncytial virus (RSV) bronchiolitis is the leading cause of infant hospitalization in the United States. Prophylaxis with palivizumab is effective in reducing RSV hospitalizations in premature infants and in infants or children with chronic lung disease or congenital heart disease. Patients with CF or those who are immunocompromised may be at increased risk for RSV infection-related complications; hence, prophylaxis may prove beneficial to these populations. The extent of palivizumab use in the CF and immunocompromised populations is variable. Palivizumab appears to be safe and may be effective in infants and young children with CF and immunocompromise. However, well-designed, randomized, controlled trials published in peer-reviewed journals are lacking, and its routine use can therefore not be recommended at this time. If used in patients with CF or those who are immunocompromised, RSV prophylaxis should be restricted to peak outbreak months in order to optimize the cost benefit of palivizumab.
William A Prescott; David J Hutchinson
Related Documents :
1118439 - Resuscitation of the newborn.
7088609 - Emergency treatment of the choking child.
3970769 - Pre-hospital iac-cpr versus standard cpr: paramedic resuscitation of cardiac arrests.
7615499 - Cytochrome b-245 of the neutrophil superoxide-generating system contains two nonidentic...
15993729 - The development and implementation of a multidisciplinary neonatal resuscitation team i...
17262039 - Post-resuscitation complications in term neonates.
10808699 - Nosocomial pneumonia in a newborn intensive care unit.
19108959 - Contemporary neonatal outcome following rupture of membranes prior to 25 weeks with pro...
1082679 - The titre of igg anti-a/b in the serum of group o mothers of incompatible infants with ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG     Volume:  16     ISSN:  1551-6776     ISO Abbreviation:  J Pediatr Pharmacol Ther     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2012-04-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101089851     Medline TA:  J Pediatr Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  77-86     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Carbamazepine-induced acute generalized exanthematous pustulosis: a case report.
Next Document:  Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.